Document Detail


Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and proteinchip technology.
MedLine Citation:
PMID:  17453148     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To discover serum biomarkers in astrocytoma patients for early detection of glioma and evaluation of prognosis. METHODS: A total of 140 serum samples were analyzed using the weak cation-exchange (WCX) chips. Among those, 73 were sera from astrocytoma patients, 56 from normal controls, and 11 from other brain tumors. For building a diagnosis model, the samples were randomly split into a training set and a test set with similar distribution of case and control samples. Proteomics profiles were obtained using a PBSII instrument and the data were analyzed with the accompanying software. RESULTS: Seven serum biomarkers were significantly deregulated in astrocytoma group comparing to the normal control group. Among them, four were up-regulated and three were down-regulated. A decision tree classification method were developed using these seven markers. A sensitivity of 84.6% and a selectivity of 84.6% were achieved to discriminate astrocytoma from normal controls. In addition, a correlation of these markers with the astrocytoma malignancy was observed. CONCLUSIONS: Proteomics approaches such as SELDI-TOF mass spectrometry could greatly facilitate the discovery of serum biomarkers in astrocytoma. The discovered biomarkers might show great potential for early detection of astrocytoma and evaluation of prognosis for those clinical suspect astrocytoma patients. However, this need warrant further study.
Authors:
Haishi Zhang; Gang Wu; Hong Tu; Fengping Huang
Related Documents :
12557048 - Extratemporal hypometabolism on fdg pet in temporal lobe epilepsy as a predictor of sei...
3122528 - The carry-over effect on the bowel habit in elderly long-term patients of long-term bul...
18614768 - Absolute spike frequency predicts surgical outcome in tle with unilateral hippocampal a...
8912488 - Early treatment of a single generalized tonic-clonic seizure to prevent recurrence.
8683768 - Fetal therapy for obstructive uropathy: diagnosis specific outcomes [corrected]
17190758 - High recurrence rate of barrett's epithelium during long-term follow-up after argon pla...
Publication Detail:
Type:  Journal Article     Date:  2007-04-24
Journal Detail:
Title:  Journal of neuro-oncology     Volume:  84     ISSN:  0167-594X     ISO Abbreviation:  J. Neurooncol.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-07-19     Completed Date:  2007-10-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8309335     Medline TA:  J Neurooncol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  315-23     Citation Subset:  IM    
Affiliation:
Department of Neurosurgery, Huashan Hospital, Fudan University, No. 12 WuLuMuQi Zhong Road, Shanghai, 200040, P.R. China. xhaishiy@yahoo.com.cn
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Astrocytoma / blood*
Brain Neoplasms / blood*
Computational Biology / methods
Humans
Protein Array Analysis*
Proteomics / methods
Sensitivity and Specificity
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization*
Tumor Markers, Biological / blood*
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line.
Next Document:  Dexamethasone inhibits proliferation and stimulates ecto-5'-nucleotidase/CD73 activity in C6 rat gli...